Open Call for Patient Group Input – Collaborative Assessment on a Medical Device for Rectum Spacers for Prostate Cancer Radiotherapy
EUnetHTA recently started a new Collaborative Assessment on a Medical Device for rectum spacers for prostate cancer radiotherapy. To find out about participation, please read more here. Input submissions will be received through EOB, Friday 5th July.
Open Call for Patient Input – Joint Assessment on a medicinal product for neovascular (wet) age-related macular degeneration (AMD).
EUnetHTA recently started a new Joint Assessment on a medicinal product for neovascular (wet) age-related macular degeneration (AMD). To find out about participation, please read more here. Input submissions will be received through 13:00, July 15th.
OTCA14 ”Robot-assisted surgery in thoracic and visceral indications”.” Final Assessment Now Available
We are pleased to announce publication of the collaborative assessment OTCA14 “Robot-assisted surgery for thoracic and visceral surgery”. This is the assessment of the relative effectiveness and safety of robot-assisted surgery for 13 different procedures within the thoracic and visceral surgery area. The assessment is based on evidence from RCTs or –in the absence of […]
OTCA18 Final Project Plan – Regional hyperthermia for high-risk soft tissue sarcoma treatment – now available
The Final OTCA18 Project Plan on ‘Regional hyperthermia for high-risk soft tissue sarcoma treatment’ is now available for access, together with comments from external experts, Haukeland Hospital, and manufacturers, and the relevant answers for each from the assessment team. Please access the Final Project Plan and related documentation via the following links: OTCA18 – Final […]
REQueST tool and its Vision paper Public Consultation – Now closed
The Haute Autorité de Santé (HAS), National Institute for Health and Care Excellence (NICE) & the Croatian Institute for Public Health (HZJZ) are pleased to share the following WP5 strand B draft outputs for an 8 week public consultation: REQueST (Registry Evaluation and Quality Standards Tool): a tool that is built upon the results of […]
OTCA11 Final Assessment – Now Available
We are pleased to announce that the collaborative rapid assessment, OTCA11, on “Custom-made or customisable 3D printed implants and cutting guides versus non-3D printed standard implants and cutting guides for improving outcome in patients undergoing knee, maxillofacial, or cranial surgery” is now available. This rapid assessment addresses the research question of whether 3D printed custom-made […]
EUnetHTA 2019 Assembly & Forum Welcome Guide – Now Available
To accompany the upcoming EUnetHTA 2019 Assembly & Forum 0n 10-11th April in Amsterdam, a Welcome Guide has been developed to give participants and attendees a thorough overview of the event proceedings, practical information, and EUnetHTA’s working activities. The guide is created through the direct input of all EUnetHTA working groups and aims to […]
Declaration of Interest and Confidentiality Agreement (DOI) – Documents Now Available
EUnetHTA has developed documentation to address Conflict of Interest (COI) concerns and assist in the decision-making process relating to the assessment of individuals potentially involved in EUnetHTA JA3 activities. The Procedure Guidance for handling Declaration of Interest (DOI) details how to approach the step-by-step template form to generate a transparent assessment of stakeholder interests. Current […]
Open Call for Patient Input – Joint Assessment on a medicinal product for secondary progressive MS.
EUnetHTA recently started a new Joint Assessment on a medicinal product for secondary progressive MS. To find out about participation, please read more here. Input submissions will be received through till EOB, April 28th.
2019 EUnetHTA Forum Agenda – Now Available
The day’s agenda is now available for the upcoming 2019 EUnetHTA Forum on 11th April at the West-Indisch Huis in central Amsterdam. We are looking forward to hosting a collaborative, informative session of talks that both outline progress made in European HTA, while scoping out expectations for the future. See the agenda HERE.
